Sen. Bill Cassidy (R-LA) led more than a dozen Republican senators in sending a letter Thursday to Food and Drug Administration (FDA) Commissioner Marty Makary, pressing for answers about the recent approval of a generic abortion pill and agency progress studying the safety and risks of mifepristone.
Cassidy, who is chairman of the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP), reminded Makary about the commitments he and Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. made during their confirmation hearings to review the safety data around mifepristone, the first drug used in a two-drug medication abortion regimen.
“Despite making these commitments to senators in the beginning of the year, FDA waited nearly six months after your confirmation before announcing any concrete action to evaluate and mitigate the safety risks of mifepristone, and even then, did so in a non-public letter to state attorneys general without any press release or public acknowledgement of the letter until a post on X by Secretary Kennedy on October 2, 2025,” senators wrote, noting that the agency has provided little information about th
Continue Reading on Breitbart
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.